<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00156130</url>
  </required_header>
  <id_info>
    <org_study_id>OCOG-2003-AROW</org_study_id>
    <secondary_id>CBCRI-Grant-014366</secondary_id>
    <nct_id>NCT00156130</nct_id>
  </id_info>
  <brief_title>Accelerated Radiotherapy Outcomes in Women</brief_title>
  <official_title>Accelerated Radiotherapy Outcomes in Women (Long Term Outcomes of a Randomized Trial of Breast Irradiation Schedules After Lumpectomy in Women With Node-Negative Breast Cancer)(AROW)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ontario Clinical Oncology Group (OCOG)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Breast Cancer Research Alliance</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ontario Clinical Oncology Group (OCOG)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is evaluating the long-term outcomes of women in a randomized trial that compared&#xD;
      accelerated whole breast irradiation (42.5 Gy in 16 fractions over 22 days) to a longer&#xD;
      conventional schedule of whole breast irradiation (50 Gy in 25 fractions over 35 days)&#xD;
      following breast-conserving surgery. The outcomes evaluated will include cosmetic outcome and&#xD;
      cardiac disease as a measure of late radiation morbidity and local breast recurrence as a&#xD;
      measure of effectiveness.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is evaluating the long-term outcomes of women in a randomized trial that compared&#xD;
      accelerated whole breast irradiation (42.5 Gy in 16 fractions over 22 days) to a longer&#xD;
      conventional schedule of whole breast irradiation (50 Gy in 25 fractions over 35 days)&#xD;
      following breast-conserving surgery. The results reported at 5 years demonstrated equivalence&#xD;
      for these two different radiation schedules for the effect of local recurrence in the breast&#xD;
      and cosmetic outcome. Emerging data has suggested that accelerated or shorter radiation&#xD;
      schedules may potentially be associated with an increased risk of late morbidity of the skin,&#xD;
      soft tissue and the heart at 10 years and beyond. The purpose of this study is to evaluate&#xD;
      the long term outcomes of women randomized in the trial. The outcomes evaluated will include&#xD;
      cosmetic outcome and cardiac disease as a measure of late radiation morbidity and local&#xD;
      breast recurrence as a measure of effectiveness.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1234</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Accelerated whole breast irradiation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Conventional whole breast irradiation</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Conventional radiotherapy schedule</intervention_name>
    <description>50 Gy in 25 fractions over 35 days</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Accelarated radiotherapy schedule</intervention_name>
    <description>42.5 Gy in 16 fractions over 22 days</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Extended long term follow-up of patients recruited into the &quot;Randomized Trial of&#xD;
        Hypofractionated Radiotherapy Post-Lumpectomy in Women with Node Negative Breast Cancer&quot;&#xD;
        study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Only patients recruited into the &quot;Randomized Trial of Hypofractionated Radiotherapy&#xD;
        Post-Lumpectomy in Women with Node Negative Breast Cancer&quot; study are eligible to be&#xD;
        enrolled into this study.&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          1. The female patient has a histological diagnosis of invasive carcinoma of the breast,&#xD;
             and no evidence of metastatic disease.&#xD;
&#xD;
          2. Has had a lumpectomy (including segmental resection and partial mastectomy), that is,&#xD;
             surgical excision of the tumour with a rim of normal tissue.&#xD;
&#xD;
          3. Patient has not had an axillary dissection, OR for patients who have had an axillary&#xD;
             dissection, all nodes are negative for metastatic disease.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Tumour greater than 5 cm in greatest diameter on pathological examination.&#xD;
&#xD;
          2. The presence of invasive or intraductal (noninvasive) breast cancer involving the&#xD;
             surgical margins.&#xD;
&#xD;
          3. Clinical evidence prior to surgery of infiltration of the skin of the involved breast&#xD;
             such as edema, ulceration, or fixation of the tumour to underlying muscle, or&#xD;
             inflammatory breast cancer.&#xD;
&#xD;
          4. Bilateral malignancy of the breast (synchronous or metachronous).&#xD;
&#xD;
          5. More than one primary invasive tumour in the same breast.&#xD;
&#xD;
          6. Previous surgery for breast cancer.&#xD;
&#xD;
          7. Pathological status of axilla is unknown.&#xD;
&#xD;
          8. Status for adjuvant systemic therapy not determined.&#xD;
&#xD;
          9. For patients not treated with adjuvant chemotherapy: unable to commence radiation&#xD;
             therapy within 16 weeks of last surgical procedure on the breast.&#xD;
&#xD;
         10. For patients treated with adjuvant chemotherapy: unable to commence radiation therapy&#xD;
             within 8 weeks of the last dose of chemotherapy.&#xD;
&#xD;
         11. Serious nonmalignant disease (eg. cardiovascular, renal, etc.) which would preclude&#xD;
             surgical or radiation treatment.&#xD;
&#xD;
         12. Currently pregnant or lactating.&#xD;
&#xD;
         13. Breast deemed too large to permit satisfactory radiation (ie. separation &gt; 25 cm).&#xD;
&#xD;
         14. Previous concomitant malignancies of any type except squamous, or basal cell&#xD;
             carcinomas of the skin, or carcinoma in situ of the cervix which have been effectively&#xD;
             treated.&#xD;
&#xD;
         15. Geographic inaccessibility for follow-up.&#xD;
&#xD;
         16. Psychiatric or addictive disorders which preclude obtaining informed consent or&#xD;
             adherence to the protocol.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy Whelan, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Juravinski Cancer Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Juravinski Cancer Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8V 5C2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Centre of Southeastern Ontario at Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 5P9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Regional Cancer Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital-Integrated Cancer Program</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 1C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niagara Health System</name>
      <address>
        <city>St. Catharines</city>
        <state>Ontario</state>
        <zip>L2R 5K3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Program of the Sudbury Regional Hospital</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <zip>P3E 5J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Care - Thunder Bay HSC</name>
      <address>
        <city>Thunder Bay</city>
        <state>Ontario</state>
        <zip>P7B 6V4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto Sunnybrook Regional Cancer Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Princess Margaret Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Windsor Regional Cancer Centre</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <zip>N8W 2X3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>May 6, 2016</last_update_submitted>
  <last_update_submitted_qc>May 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>Lumpectomy</keyword>
  <keyword>Radiotherapy</keyword>
  <keyword>Hypofractionated Radiotherapy</keyword>
  <keyword>Long Term Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

